2025. Sagacious Aldose Reductase Inhibition for Treatment of Metabolic Disorders. Journal of Carcinogenesis. 24, 9s (Oct. 2025), 410–418. DOI:https://doi.org/10.64149/J.Carcinog.24.9s.410-418.